Shielding of hepatitis B virus-like nanoparticle with poly(2-ethyl-2-oxazoline)

Virus-like nanoparticles (VLNPs) have been studied extensively as nanocarriers for targeted drug delivery to cancer cells. However, VLNPs have intrinsic drawbacks, in particular, potential antigenicity and immunogenicity, which hamper their clinical applications. Thus, they can be eliminated easily...

Full description

Bibliographic Details
Main Authors: Fam, See Yee, Chee, Chin Fei, Yong, Chean Yeah, Ho, Kok Lian, Abdul Razak, Mariatulqabtiah, Lau, Han Yih, Tan, Wen Siang
Format: Article
Language:English
Published: MDPI 2019
Online Access:http://psasir.upm.edu.my/id/eprint/38249/
http://psasir.upm.edu.my/id/eprint/38249/1/38249.pdf

Similar Items